Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Brussels - Delayed Quote EUR

European Medical Solutions (ALEMS.BR)

5.50
+0.65
+(13.39%)
At close: April 25 at 2:14:01 PM GMT+2
Loading Chart for ALEMS.BR
  • Previous Close 4.85
  • Open 5.00
  • Bid --
  • Ask --
  • Day's Range 5.00 - 5.50
  • 52 Week Range 0.84 - 13.02
  • Volume 533
  • Avg. Volume 161
  • Market Cap (intraday) 23.275M
  • Beta (5Y Monthly) 0.62
  • PE Ratio (TTM) --
  • EPS (TTM) -0.28
  • Earnings Date Jul 16, 2025 - Jul 21, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

European Medical Solutions engages in the design, development, and manufacturing of medical imaging systems for digital radiology and bone densitometry in Belgium. It offers R/F solutions, including PLATINUM NEO, a smart solution that revolutionizes the R/F workflow, as well as OPTIMA dRF, a robust solution; bone densitometry and body composition analysis equipment; chest and bone rooms, such as floor and ceiling tube stands; ambulatory radiography equipment; retrofit kits; C-ARM mobile operating room solutions; and mammography solutions. The company was formerly known as DMS Imaging SA and changed its name to European Medical Solutions in June 2024. DMS Imaging SA was founded in 1979 and is headquartered in Ixelles, Belgium. European Medical Solutions operates as a subsidiary of Diagnostic Medical Systems S.A.

www.dms-imaging.com

122

Full Time Employees

December 31

Fiscal Year Ends

Recent News: ALEMS.BR

View More

Performance Overview: ALEMS.BR

Trailing total returns as of 4/25/2025, which may include dividends or other distributions. Benchmark is BEL 20 (^BFX) .

YTD Return

ALEMS.BR
17.91%
BEL 20 (^BFX)
1.89%

1-Year Return

ALEMS.BR
21.09%
BEL 20 (^BFX)
11.62%

3-Year Return

ALEMS.BR
90.59%
BEL 20 (^BFX)
4.41%

5-Year Return

ALEMS.BR
94.40%
BEL 20 (^BFX)
46.32%

Compare To: ALEMS.BR

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ALEMS.BR

View More

Valuation Measures

Annual
As of 4/25/2025
  • Market Cap

    23.28M

  • Enterprise Value

    38.68M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.56

  • Price/Book (mrq)

    2.29

  • Enterprise Value/Revenue

    0.93

  • Enterprise Value/EBITDA

    22.44

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.14%

  • Return on Assets (ttm)

    1.70%

  • Return on Equity (ttm)

    5.40%

  • Revenue (ttm)

    47.91M

  • Net Income Avi to Common (ttm)

    546k

  • Diluted EPS (ttm)

    -0.28

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    4.58M

  • Total Debt/Equity (mrq)

    191.98%

  • Levered Free Cash Flow (ttm)

    -3.45M

Research Analysis: ALEMS.BR

View More

Company Insights: ALEMS.BR

Research Reports: ALEMS.BR

View More